Olive-Derived Vesicles: A New Frontier in Cancer Treatment
In a groundbreaking study conducted by the HonorHealth Research Institute in Scottsdale, scientists have discovered a novel use for olives in the field of medicine. The research suggests that olives could play a vital role in enhancing drug delivery systems for cancer treatments.
The study focuses on vesicles, which are small sacs formed by membranes containing liquid, capable of transporting drugs to target cells. These vesicles occur naturally in both humans and plants, but the research highlights the potential of olive-derived vesicles as a new drug delivery mechanism. This method promises to be less toxic and more precisely targeted toward specific diseases.
Frederic Zenhausern, a senior investigator at the institute, emphasized the innovative nature of this treatment, which utilizes byproducts from agricultural olive processing. Zenhausern remarked on the vesicles’ stability under various conditions, stating, “And they are extremely stable under different conditions. For example — we can almost store them in your fridge or even at room temperature for months and they are still stable.”
Unlike certain vaccines requiring freezing temperatures for storage, these olive-derived vesicles offer a more convenient and practical alternative. The findings indicate potential advancements in the effective use of anti-cancer drugs, gene editing technologies, and the development of modern RNA-based therapeutics.
The study concludes that olive-derived nanovesicles are promising candidates for drug nanocarriers in various clinical applications, demonstrating “biocompatibility, high resistance to stress, good stability in harsh environments, and improvement of anticancer drug efficacy.”
—
Read More Arizona News
